Allergan cuts 1,500 jobs, faces SEC complaint

Botox-maker Allergan announces restructuring measures that will cut 13% of its global workforce as the company sinks deeper into a months-long battle against activist investors and attempts at a takeover. Updated July 21, 2014, at 12:40 p.m. EST with additional information on Allergan's earnings. Pershing Capital Management, Valeant Pharmaceuticals, Allergan Inc.News Well, Cosmetic/Aesthetic, Layoffs, Mergers & Acquisitions, Personnel Moves, Pharmaceuticals, Wall Street Beatread more
Source: Mass Device - Category: Medical Equipment Authors: Source Type: news